無標定檢測市場規模、佔有率及成長分析（按產品、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，無標定檢測市場規模將達到 15.2 億美元，到 2025 年將達到 16.5 億美元，到 2033 年將達到 31.7 億美元，在預測期（2026-2033 年）內複合年成長率為 8.5%。

無標定檢測系統是一種創新的整合技術，無需依賴螢光或標記技術即可分析生物分子間的相互作用。這些系統為藥物發現提供了一種快速、即時的方法，並在生化和細胞分析中有廣泛的應用。無標定檢測市場正呈現強勁成長勢頭，這主要得益於先進技術產品的推出以及產學研合作的日益密切，從而推動了藥物舉措。其他推動市場擴張的因素包括研究經費的增加以及無標定技術卓越的靈敏度。此外，製藥和生物技術領域研發活動的日益重要，以及終端用戶對無標定檢測方法優勢的認知不斷提高，預計都將顯著促進該行業的成長。

無標定檢測市場促進因素

新興市場生命科學研究的進步以及更靈敏、無標記技術的持續發展，推動了無標定檢測市場顯著成長。這種快速成長為企業提供了眾多創新機遇，以滿足日益成長的高效產品需求。最尖端科技產品的推出，使得人們能夠探索分子相互作用，而無需面對標記帶來的複雜問題，例如猝滅效應。此外，無標定技術作為高通量篩檢領域相對較新的技術，能夠研究生物分子相互作用，避免空間干擾或螢光的影響，從而提高分析的準確性和效率。

限制無標定檢測市場的因素

無標定檢測市場的成長受到高成本的顯著限制。此外，潛在使用者群體對無標定檢測技術的廣泛應用，使其無法充分發揮潛力。因此，除非這些限制因素得到解決，否則無標定檢測市場可能難以實現顯著成長並在各個應用領域中廣泛應用。

無標定檢測市場趨勢

由於技術的快速發展和策略合作，無標定檢測市場正經歷顯著成長。生物層干涉（BLI）和表面等離子體共振（SPR）等創新技術正在提升檢測系統的性能，使其更易於研究人員使用，效率更高。特別是，康寧® Epic® BT 等緊湊型桌上型偵測儀的推出，憑藉其方便用戶使用的介面和經濟高效的設計，正在革新檢測流程。康寧與 Advenus Therapeutics 等公司之間的夥伴關係，正在促進這些先進技術的更廣泛應用，並拓展其在藥物發現和檢測方法開發中的應用範圍。這種協同效應有望推動市場實現前所未有的擴張。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

全球無標定檢測市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 消耗品
  • 生物感測器晶片
  • 微孔盤
• 裝置

全球無標定檢測市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 生物層干涉測量
• 差示掃描量熱法
• 等溫滴定量檢測法
• 表面等離子體共振
• 質譜分析
• 其他無標定檢測技術

全球無標定（按應用領域及複合年成長率分類）（2026-2033 年）

• 結合動力學
• 鍵動態
• 內源性受體檢測
• 命中確認
• 潛在客戶開發
• 其他

全球無標定檢測市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥和生物技術公司
• 學術和研究機構
• CRO（合約研究組織）

全球無標定檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Agilent Technologies, Inc.（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• GE Healthcare（USA）
• Thermo Fisher Scientific Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Horiba, Ltd.（Japan）
• Malvern Panalytical Ltd.（UK）
• Bruker Corporation（USA）
• Waters Corporation（USA）
• Shimadzu Corporation（Japan）
• Corning Incorporated（USA）
• Hitachi High-Tech Corporation（Japan）
• Molecular Devices, LLC（USA）
• Sartorius AG（Germany）
• BiOptix Analytical LLC（USA）
• Attana AB（Sweden）
• XanTec Bioanalytics GmbH（Germany）

結論與建議

Label Free Detection Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.65 Billion in 2025 to USD 3.17 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

Label-free detection systems are innovative integrated technologies that allow for the examination of biomolecular interactions without relying on fluorescence or labeling techniques. These systems offer a rapid and real-time method for drug discovery, with key applications in biochemical and cell-based assays. The label-free detection market is witnessing robust growth, driven by the launch of advanced technological products and an increase in academic-industrial collaborations that boost drug discovery initiatives. Additional factors fueling market expansion include heightened research funding and the remarkable sensitivity of label-free technologies. Furthermore, the growing focus on pharmaceutical and biotechnology R&D activities, coupled with rising awareness among end-users regarding the advantages of label-free detection methods, is expected to significantly enhance industry growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Label Free Detection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Label Free Detection Market Segments Analysis

Global Label Free Detection Market is segmented by product, technology, application, end-user and region. Based on product, the market is segmented into consumables and instruments. Based on technology, the market is segmented into bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, surface plasmon resonance, mass spectrometry and other LFD technologies. Based on application, the market is segmented into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation and other. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Label Free Detection Market

The label-free detection market is experiencing significant growth due to advancements in life sciences research in emerging markets and the ongoing development of more sensitive non-marker technologies. This surge presents numerous opportunities for companies to innovate and cater to the increasing demand for efficient product delivery. The introduction of state-of-the-art technological products facilitates the exploration of molecular interactions without the complications associated with labels, such as quenching effects. Furthermore, label-free technologies, while relatively novel in the established domain of high-throughput screening, enable researchers to investigate biomolecular interactions without the hindrances of spatial interference or autofluorescence, thereby enhancing analysis accuracy and effectiveness.

Restraints in the Label Free Detection Market

The growth of the label-free detection market is considerably restricted by the high costs associated with the necessary instruments for this technology. Additionally, a notable barrier to the market's development is the limited awareness among potential users regarding the benefits that label-free detection offers. This combination of expensive equipment and insufficient understanding of its advantages hinders broader adoption and impedes the market's ability to reach its full potential. As a result, without addressing these constraints, the label-free detection market may struggle to achieve significant growth and wider implementation in various applications.

Market Trends of the Label Free Detection Market

The Label-Free Detection market is witnessing significant growth driven by rapid technological advancements and strategic collaborations. Innovations such as Bio-layer Interferometry (BLI) and Surface Plasmon Resonance (SPR) are enhancing the capabilities of detection systems, making them more accessible and efficient for researchers. Notably, the introduction of compact benchtop models, like the Corning(R) Epic(R) BT, is revolutionizing assay processes with user-friendly interfaces and cost-effective designs. Partnerships between companies, such as Corning and Advinus Therapeutics, facilitate wider adoption of these advanced technologies, thereby expanding their application in drug discovery and assay development. This synergy is set to propel the market towards unprecedented expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Label Free Detection Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Biosensor Chips
  • Microplates
• Instruments

Global Label Free Detection Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Bio-Layer Interferometry
• Differential Scanning Calorimetry
• Isothermal Titration Calorimetry
• Surface Plasmon Resonance
• Mass Spectrometry
• Other LFD Technologies

Global Label Free Detection Market Size by Application & CAGR (2026-2033)

• Market Overview
• Binding Kinetics
• Binding Thermodynamics
• Endogenous Receptor Detection
• Hit Confirmation
• Lead Generation
• Other

Global Label Free Detection Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Global Label Free Detection Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, End-User)
  • USA
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Malvern Panalytical Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi High-Tech Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiOptix Analytical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Attana AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XanTec Bioanalytics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations